Other secondary hypertension
ICD-10 I15.8 is a billable code used to indicate a diagnosis of other secondary hypertension.
I15.8 refers to other secondary hypertension, a condition characterized by elevated blood pressure due to identifiable underlying causes. Unlike primary hypertension, which has no specific origin, secondary hypertension can result from various cardiovascular diseases, endocrine disorders, renal diseases, or certain medications. Clinically, patients may present with symptoms such as headaches, dizziness, or visual disturbances, but many remain asymptomatic until complications arise. The anatomy involved primarily includes the cardiovascular system, particularly the heart and blood vessels, as well as the kidneys and endocrine glands, which play crucial roles in blood pressure regulation. Disease progression can lead to serious complications, including heart failure, stroke, and chronic kidney disease if not properly managed. Diagnostic considerations include a thorough patient history, physical examination, and targeted laboratory tests to identify the underlying cause of hypertension, such as imaging studies or hormonal assays. Accurate diagnosis is essential for effective treatment and management of secondary hypertension.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I15.8 encompasses various conditions leading to secondary hypertension, including renal artery stenosis, Cushing's syndrome, hyperaldosteronism, pheochromocytoma, and certain medications such as NSAIDs and corticosteroids.
I15.8 should be used when hypertension is secondary to a specific identifiable condition, as opposed to I10, which is used for essential hypertension without a known cause.
Documentation should include a detailed patient history, results of diagnostic tests identifying the underlying cause, and evidence of hypertension management, including treatment plans and follow-up evaluations.
